Product Wiki · Recalls · Health Canada Consumer Product Safety

Recall 23032 — Antipsychotic drugs: Labelling update regarding the risk of abnormal muscle movements and withdrawal symptoms in newborns exposed during pregnancy

Health Canada Consumer Product Safety · Canada · 2011-06-15

AI-assisted, human-edited — this page is drafted with AI from public-source data, then reviewed before publication. How we use AI →
Agency
Health Canada Consumer Product Safety
Recall identifier
23032
Date of alert
2011-06-15
Country / jurisdiction
Canada
Risk type
recall
Product category
Drugs
Product type
Communications and Public Affairs Branch
Reported risk: New safety information
Primary source: https://recalls-rappels.canada.ca/en/alert-recall/antipsychotic-drugs-labelling-

Verify each fact at the issuing agency before acting. Recall scope, affected lots, and remediation instructions may be updated by the agency after our last sync.

Related

ProductGuru indexes recall and safety-alert records from ~30 public agency registries. We are not lawyers, regulators or product-safety consultants. This page restates what the named agency published; consult the primary source above (or qualified counsel in your jurisdiction) before any commercial, medical or safety decision.